Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Mon, Sep 16, 2024
[Archive]
Volume 15, Issue 1 (Winter 2024)
Caspian J Intern Med 2024, 15(1): 58-65 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ahmadzade A, Simani L, Roozbeh M, Farsad F, Sheibani M, Negaresh O, et al . Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus. Caspian J Intern Med 2024; 15 (1) :58-65
URL: http://caspjim.com/article-1-3772-en.html
URL: http://caspjim.com/article-1-3772-en.html
Arman Ahmadzade 
, Leila Simani , Mehrdad Roozbeh , Farane Farsad , Mehdi Sheibani , Omid Negaresh , Mohammad Mehdi Emam , Alireza Rajaei , Muhanna Kazempour * , Mahtab Ramezani , Samad Nazarpoor
, Leila Simani , Mehrdad Roozbeh , Farane Farsad , Mehdi Sheibani , Omid Negaresh , Mohammad Mehdi Emam , Alireza Rajaei , Muhanna Kazempour * , Mahtab Ramezani , Samad Nazarpoor
Department of Rheumatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran , muhannakazempour@gmail.com
Abstract: (754 Views)
Background: Diagnosis of neuropsychiatric systemic lupus erythematosus (NPSLE) is challenging due to nonspecific biomarkers. High serum levels of neurofilament protein light subunit (NFL), high mobility group box 1 (HMGB1), Matrix metalloproteinase-9 (MMP-9) and have been reported in several autoimmune diseases. The aim of this study was to examine whether their plasma levels could serve as a diagnostic or prognostic biomarker for NPSLE.
Methods: There were 90 SLE patients enrolled in this cross-sectional study (87.8% women and 12.2% men with a mean age of 41.67±11.05 years). We assessed the mental status of patients, also we measured the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus International Collaborating Clinics/ACR (SLICC/ ACR) Damage Index or SDI scores. Serum levels of NFL, HMGB1, MMP9, and ds-DNA were investigated to find a role in the pathophysiology of NPSLE.
Results: Among the 90 patients with SLE, 63 (70%) met the criteria of NPSLE syndrome. Our results have shown a notable difference concerning SEDIAC-2k score, SDI score, PANS, MoCA, and Beck anxiety depression, between the two groups (p < 0.05). Although serum level of all measured serum biomarkers (NFL, MMP-9, HMGB1, dsDNA) were higher in patients with NPSLE, the difference was not statistically significant. Interestingly, our results showed that the serum level of NFL was correlated with the serum level of HMGB-1 and MMP-9. (r: 0.411, P=0.003).
Conclusion: Serum level of NFL, HMGB-1 and MMP-9 may be used to detect abnormal mental status in patients with SLE.
Methods: There were 90 SLE patients enrolled in this cross-sectional study (87.8% women and 12.2% men with a mean age of 41.67±11.05 years). We assessed the mental status of patients, also we measured the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus International Collaborating Clinics/ACR (SLICC/ ACR) Damage Index or SDI scores. Serum levels of NFL, HMGB1, MMP9, and ds-DNA were investigated to find a role in the pathophysiology of NPSLE.
Results: Among the 90 patients with SLE, 63 (70%) met the criteria of NPSLE syndrome. Our results have shown a notable difference concerning SEDIAC-2k score, SDI score, PANS, MoCA, and Beck anxiety depression, between the two groups (p < 0.05). Although serum level of all measured serum biomarkers (NFL, MMP-9, HMGB1, dsDNA) were higher in patients with NPSLE, the difference was not statistically significant. Interestingly, our results showed that the serum level of NFL was correlated with the serum level of HMGB-1 and MMP-9. (r: 0.411, P=0.003).
Conclusion: Serum level of NFL, HMGB-1 and MMP-9 may be used to detect abnormal mental status in patients with SLE.
Keywords: Systemic lupus erythematosus, Cognitive disorders, Neuropsychiatric systemic lupus erythematosus, Autoantibodies, neuroinflammation
Type of Study: Original Article |
Subject:
Reumatology
Received: 2022/12/1 | Accepted: 2023/04/17 | Published: 2024/01/19
Received: 2022/12/1 | Accepted: 2023/04/17 | Published: 2024/01/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
